The enhanced interaction between T372-phosphorylated EZH2 and STAT3 reduced STAT3 phosphorylation, downregulating interleukin 6 receptor expression and inhibiting the cell proliferation and migration of epithelial ovarian cancer cells in vitro and decreasing ovarian xenograft tumor growth in vivo [44]. This evidence concerns the gene STAT3 and ovarian carcinoma.